CHARLES RIVER LABORATORIES EDINBURGH LIMITEDActive

Company number SC091725Private limited companyIncorporated 1985

Key figures

£89,227,000+8.2%
Net assets 2025
+8.2%
Average annual growth 2024–2025
025 m50 m75 m100 m20242025

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 m100 m150 m20242025
Filed accounts2024–2025
20242025
Turnover135,388,000127,949,000
Profit for the year21,955,00016,595,000
Total assets122,158,000130,056,000
Total liabilities——
Net assets / total equity82,444,00089,227,000
Average number of employees1,3591,236
Average pay (per year)46,13151,548

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the Company is to contract scientific research and consultancy on behalf of the pharmaceutical, agrochemical and veterinary sectors. The company does not undertake standalone research

As described in the company's latest filed accounts.

Summary: CHARLES RIVER LABORATORIES EDINBURGH LIMITED

Company

CHARLES RIVER LABORATORIES EDINBURGH LIMITED is a private limited company registered with Companies House under company number SC091725. It was incorporated on 18 Feb 1985. Its status is active. Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).

Accounts

The latest accounts in the database are for 2025 (period ending 27 Dec 2025); the company files full accounts. Turnover was £127,949,000. Profit for the year was £16,595,000. Net assets were £89,227,000, up 8.2% on the previous year. The company had an average of 1,236 employees. Figures are available for 2 financial years (2024–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 12 Jul 2027.